Results 151 to 160 of about 40,578 (245)
Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials
Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1036-1048, February 2026.Abstract Aims
To evaluate the effectiveness and safety of early initiation of subcutaneous (SC) basal insulin in combination with intravenous insulin infusion (IVII), compared with IVII alone, for the management of diabetic ketoacidosis (DKA). Materials and Methods
A systematic search of PubMed, Embase, Scopus, and the Cochrane Library was conducted to Kitti Thammakosol, Patteera Vongtangton, Pawin Numthavaj, Arunrat Auttara‐atthakorn, Chutintorn Sriphrapradang +4 morewiley +1 more sourceA nationwide 12‐month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events
Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1179-1190, February 2026.Abstract Aims
A nationwide observational study was conducted to assess the 12‐month effectiveness of AID systems in the routine care of people with Type 1 diabetes (PwT1D). Methods
All PwT1D, adults, and children, who initiated AID between January 1, 2022, and December 31, 2022, were included across 79 centres.Jean‐Pierre Riveline, Jean‐Baptiste Julla, Elisabeth Bonnemaison, Michael Joubert, Sandrine Lablanche, Agnès Sola Gazagnes, Delphine Demarsy, Didier Gouet, Pauline Schaepelynck, Chloé Amouyal, Fabienne Dalla Vale, Anne Schletzer‐Mari, Sylvaine Clavel, Anne Spiteri, Catherine Campinos, Sandrine Favre, Igor Tauveron, Laurence Mathivon, Sophie Borot, Guy Fagherazzi, Marc D. Breton, Jean‐François Gautier, Eric Renard, for the OB2F study group, Jean‐Pierre Riveline, Manal Al Masri‐Shbat, Emmanuel Cosson, Isabela Banu, Michael Joubert, Agnès Sola Gazagnes, Gaetan Prevost, Sandrine Lablanche, Pauline Schaepelynck, Charles Thivolet, Nicolas Chevalier, Sophie Borot, Bruno Guerci, Elise Bismuth, Jacques Beltrand, Delphine Demarsy, Emmanuelle Bourrinet, Didier Gouet, Lucien Marchand, Louis Gerbaud‐Morlaes, Salha Fendri, Sylvaine Clavel, René Valero, Emmanuel Sonnet, Blandine Delenne, Jean‐Paul Donnet, Emma Carreira, Cedric Fagour, Camille Vatier, Rosine Guintrand, Luc Rakotoarisoa, Aurélie Carlier, Anne Spiteri, Igor Tauveron, Lemoine Amal, Letitia Pantalone, Anne Schletzer, Karen Berthelon, Natacha Germain, Françoise Latil Plat, Aroua Temessek, Marie Mansilla, Lorraine Thomesse, Fabienne Dalla Valle, Anne‐Cécile Paepegaey, Nadège Bachere, Candace Ben Signor, Samy Hadjadj, Thanh Lan Dangduy, Mathieu Giraud, Sandrine Favre, Joëlle Dupont, Anna Flaus Furmaniuk, Laure Houdon Nguyen, Patricia Pigeon Kherkiche, Anne‐Cécile Gauthier, Anne Vambergue, Alina Radu, Sandra Pochelu, Abine Baron, Chloé Amouyal, Jennifer Allain‐Cohen, Mariana Geamanu, Florent Verdier, Yannis Chartier, Nathalie Garrec, Annie Sfez, laurence Mathivon, Christine Rouby, Emeline Renard, Agnès Tamboura, Leïla Mchirgui, PH Emilie Georget, Elise Pinto da Rocha, Laure Oilleau‐Barral +98 morewiley +1 more sourceEfficacy and safety of bi‐weekly cofrogliptin treatment replacing daily dipeptidyl peptidase‐4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open‐label, randomized controlled phase 2 trial
Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1191-1200, February 2026.Abstract Aim
This study aimed to investigate the efficacy and safety of bi‐weekly cofrogliptin treatment as a replacement for daily dipeptidyl peptidase‐4 inhibitors (DPP‐4is) in Chinese patients with type 2 diabetes mellitus (T2DM). Methods
This multicenter, open‐label, randomized controlled study assigned participants in a 1:1 ratio to either the ...Congqing Pan, Hongwei Jiang, Yi Feng, Suijun Wang, Jin Zhang, Zhongjing Wang, Yusen Zhou, Fangqiong Li, Zhanhui Zhang, Yaming Li, Liming Chen +10 morewiley +1 more source